Literature DB >> 10488078

Deletion of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A.

D Thomas1, W Zhang, C A Karle, S Kathöfer, W Schöls, W Kübler, J Kiehn.   

Abstract

We investigated the role of protein kinase A (PKA) in regulation of the human ether-a-go-go-related gene (HERG) potassium channel activation. HERG clones with single mutations destroying one of four consensus PKA phosphorylation sites (S283A, S890A, T895A, S1137A), as well as one clone carrying all mutations with no PKA phosphorylation sites (HERG 4M) were constructed. These clones were expressed heterologously in Xenopus oocytes, and HERG potassium currents were measured with the two microelectrode voltage clamp technique. Application of the cAMP-specific phosphodiesterase (PDE IV) inhibitor Ro-20-1724 (100 microM), which results in an increased cAMP level and PKA stimulation, induced a reduction of HERG wild type outward currents by 19.1% due to a shift in the activation curve of 12.4 mV. When 100 microM Ro-20-1724 was applied to the HERG 4M channel, missing all PKA sites, there was no significant shift in the activation curve, and the current amplitude was not reduced. Furthermore, the adenylate cyclase activator forskolin that leads to PKA activation (400 microM, 60 min), shifted HERG wild type channel activation by 14.1 mV and reduced currents by 39.9%, whereas HERG 4M channels showed only a small shift of 4.3 mV and a weaker current reduction of 22.3%. We conclude that PKA regulates HERG channel activation, and direct phosphorylation of the HERG channel protein has a functional role that may be important in regulation of cardiac repolarization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10488078     DOI: 10.1074/jbc.274.39.27457

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Functional characterization of the C-terminus of the human ether-à-go-go-related gene K(+) channel (HERG).

Authors:  E Aydar; C Palmer
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

2.  14-3-3 amplifies and prolongs adrenergic stimulation of HERG K+ channel activity.

Authors:  Anna Kagan; Yonathan F Melman; Andrew Krumerman; Thomas V McDonald
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

3.  Modulation of homomeric and heteromeric KCNQ1 channels by external acidification.

Authors:  Asher Peretz; Hella Schottelndreier; Liora Ben Aharon-Shamgar; Bernard Attali
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

4.  TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation.

Authors:  C Seyler; E Duthil-Straub; E Zitron; J Gierten; E P Scholz; R H A Fink; C A Karle; R Becker; H A Katus; D Thomas
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

5.  Effects of β-adrenoceptor stimulation on delayed rectifier K(+) currents in canine ventricular cardiomyocytes.

Authors:  G Harmati; T Bányász; L Bárándi; N Szentandrássy; B Horváth; G Szabó; J A Szentmiklósi; G Szénási; P P Nánási; J Magyar
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

6.  Rac GTPase signaling through the PP5 protein phosphatase.

Authors:  Saverio Gentile; Thomas Darden; Christian Erxleben; Charles Romeo; Angela Russo; Negin Martin; Sandra Rossie; David L Armstrong
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

7.  PKA phosphorylation of HERG protein regulates the rate of channel synthesis.

Authors:  Jian Chen; Jakub Sroubek; Yamini Krishnan; Yan Li; Jinsong Bian; Thomas V McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-20       Impact factor: 4.733

8.  Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channels.

Authors:  Dierk Thomas; Sven Kathofer; Wei Zhang; Kezhong Wu; Anna-Britt Wimmer; Edgar Zitron; Volker A W Kreye; Hugo A Katus; Wolfgang Schoels; Christoph A Karle; Johann Kiehn
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

9.  The human cardiac K2P3.1 (TASK-1) potassium leak channel is a molecular target for the class III antiarrhythmic drug amiodarone.

Authors:  Jakob Gierten; Eckhard Ficker; Ramona Bloehs; Patrick A Schweizer; Edgar Zitron; Eberhard Scholz; Christoph Karle; Hugo A Katus; Dierk Thomas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-24       Impact factor: 3.000

10.  Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells.

Authors:  J Jehle; E Ficker; X Wan; I Deschenes; J Kisselbach; F Wiedmann; I Staudacher; C Schmidt; P A Schweizer; R Becker; H A Katus; D Thomas
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.